NetEase Inc vs uniQure N.V. Ordinary Shares — how do they compare? NetEase Inc trades at $124.81 (market cap $80.44B), while uniQure N.V. Ordinary Shares trades at $21.53 (market cap $1.45B). The key difference: NetEase Inc is far larger — about 55.5× uniQure N.V. Ordinary Shares's market cap, and NetEase Inc pays a 2.37% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold NetEase Inc for 73 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| NTES | QURE | |
|---|---|---|
Market Cap | $80.44B | $1.45B |
Volume | 626,220 | 3,323,243 |
Sector | Technology | Health |
52-Week High | $152.85 | $70.59 |
52-Week Low | $109.26 | $9.03 |
Typical Hold Time | 73 Days | 0 Days |
Enterprise Value | $56.12B | $707.46M |
Dividend Yield | 2.37% | — |
Signals from Pluang's Aura AI — not financial advice
NTES trades at $124.76, down 0.52% on the day, with a bullish technical signal from moving averages and ADX indicators. The company reported Q2 2026 revenue of $4.4 billion, up 8% year-over-year, but missed EPS expectations. Analyst consensus is strongly bullish with an 81.82% buy rating and a $168.00 price target, implying significant upside. Strong profitability metrics include a 67.15% gross margin and 27.88% net income margin, supported by robust cash flow from operations of $50.74 billion in 2025.
The outlook for NTES remains positive given its solid fundamentals, high analyst confidence, and technical momentum. Key opportunities include global expansion and AI investments, while risks involve earnings volatility and competitive pressures in the gaming sector. The stock's current valuation at a P/E of 16.44 offers room for growth relative to historical performance and sector peers.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →